Aklanonic acid‐producing mutants of Streptomyces galilaeus and Streptomyces peucetius var. caesius
- 10 January 1987
- journal article
- research article
- Published by Wiley in Journal of Basic Microbiology
- Vol. 27 (2) , 107-111
- https://doi.org/10.1002/jobm.3620270212
Abstract
A number of blocked mutants was investigated which were obtained from taxonomically identified Streptomyces strains producing anthracyclines. Two of these mutants, NTG 061 derived from S. galilaeus F 198 and mutant 135 derived from S. peucetius var. caesius 601 F.I.1), accumulated an anthraquinone derivative which was identified as aklanonic acid. The results supplied further evidence that this compound was an intermediate of the biosynthetic pathway leading to different types of anthracyclines. It occurred before ring closure to the final tetracyclic anthracyclinone skeleton.This publication has 7 references indexed in Scilit:
- Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains ofStreptomyces galilaeus andStreptomyces peucetiusJournal of Basic Microbiology, 1986
- Preparation of labeled aklanonic acid and its bioconversion to anthracyclinones by mutants of Streptomyces griseus.The Journal of Antibiotics, 1985
- Isolation and chemical structure of aklanonic acid, an early intermediate in the biosynthesis of anthracyclines.The Journal of Antibiotics, 1985
- Microbial transformation of aklanonic acid, a potential early intermediate in the biosynthesis of anthracyclines.The Journal of Antibiotics, 1984
- New anthracyclinone metabolites from two blocked mutants of Streptomyces galilaeus MA144-M1.The Journal of Antibiotics, 1982
- Cooperative Description of Type Strains of Streptomyces: V. Additional DescriptionsInternational Journal of Systematic and Evolutionary Microbiology, 1972
- Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesiusBiotechnology & Bioengineering, 1969